Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The pharmaceutical company Amylin Pharmaceuticals licensed the compound and spent years developing it into a drug suitable for human use
BRD4 Proteolysis Targeting Chimera (PROTAC) ARV-825, Causes Sustained Degradation of BRD4 and Modulation of Chemokine Receptors, Cell Adhesion and Metabolic Targets in Leukemia Resulting in Profound Anti-Leukemic Effects
WHEAT proteins , pea proteins, rice proteins, EGG whites, MILK whey proteins , acacia fiber, BUTTER , coconut oil ( MCT ), maltitol, erythritol, chocolate drops (cocoa, cocoa BUTTER , sunflower lecithin) 2%, emulsifier: sunflower lecithin, E471 , raising agents: sodium bicarbonate, sodium hydrogen pyrophosphate, preservatives: potassium sorbate, vanilla flavor, L-carnitine
It has two main functions: 1
The second variable was to account for possible heterogeneity in the effectiveness within a drug class (for example, for empagliflozin, this variable grouped all patients who used that drug
US$ 25.63
US$ 25.72
US$ 24.59
US$ 23.55
US$ 27.91
US$ 23.93
US$ 29.94
